Lifesaving Medical and Non-medical Supplies for the Health Sector in the Gaza Strip
In line with the Good Humanitarian Donorship (GHD) principles, Switzerland recognizes the necessity of predictable and flexible funding to respond to changing needs in humanitarian crises, including protracted ones. Through an emergency funding to the World Health Organisation (WHO), SDC allows WHO to provide protection and assistance to those who are mostly affected by the latest deterioration of the health situation in the Gaza Strip through direct provision of lifesaving medical and non-medical supplies for the health sector.
Country/region | Topic | Period | Budget |
---|---|---|---|
Occupied Palestinian Territory |
Health nothemedefined
Medical services
|
01.09.2017
- 31.12.2017 |
CHF 1’005’000
|
- Essential lifesaving drugs are made available at the Central Drugs Store in the Gaza Strip and the number of drugs and disposables at zero stock is reduced.
- Essential lifesaving equipment is made available at Gazan hospitals, thus improving access to healthcare for patients.
- Lifesaving drugs and equipment procured following WHO’s established procurement procedures.
- Procured lifesaving drugs and equipment are delivered to targeted healthcare facilities in the Gaza Strip.
- World Health Organization
-
Sector according to the OECD Developement Assistance Commitiee categorisation HEALTH
Sub-Sector according to the OECD Developement Assistance Commitiee categorisation Medical services
Cross-cutting topics Human rights
The project also supports partner organisation improvements
Aid Type Project and programme contribution
Project number 7F09873
Background | Health service delivery in the Gaza Strip has been severely affected by the over 10-year-long closure imposed by Israel, and recent developments, including the ongoing electricity crisis, pushing the health sector to the brink of collapse. Since June 2017, Gaza has had only 4-6 hours of electricity per day, forcing hospitals to rely on back-up generators. Essential drugs and disposables have significantly depleted in supplies and critical elements of the health sector, such as vaccination storage, blood banks, and surgery are now under severe risk. |
Objectives | Critical health services for the Gaza Strip population are maintained and avoidable mortality and morbidity are reduced. |
Target groups | Generally, all patients seeking medical treatment in the Gaza Strip are targeted. More specifically, drugs procured under this allocation will target acutely vulnerable patients, who need emergency care. Another group of acutely vulnerable patients, who will benefit from the project, are those who suffer from chronic diseases. |
Medium-term outcomes |
|
Results |
Expected results: |
Directorate/federal office responsible |
SDC |
Credit area |
Humanitarian aid |
Project partners |
Contract partner United Nations Organization (UNO) |
Coordination with other projects and actors | WHO will liaise closely with the Central Drugs Store in the Gaza Strip and the Palestinian Ministry of Health (MoH) to identify the needs and take account of all donations received. WHO will also coordinate with other health sector partners by sharing information and collaborating efforts to harmonize work and avoid any duplications. Special attention will be paid to the drugs that are required for emergency lifesaving treatment. |
Budget | Current phase Swiss budget CHF 1’005’000 Swiss disbursement to date CHF 1’003’290 Total project since first phase Budget inclusive project partner CHF 1’005’000 |
Project phases |
Phase 1 01.09.2017 - 31.12.2017 (Completed) |